Hyperthyroidism due to Thyrotropin-Secreting Pituitary Tumors: Diagnostic and Therapeutic Considerations

Robert C. Smallridge, Charles E. Smith

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


Hyperthyroidism may be caused by the inappropriate secretion of thyroid-stimulating hormone (TSH) from a pituitary tumor. Of 33 reported cases, 17 have occurred in women and 16 have occurred in men. All patients had large tumors, and secretion of a second hormone (growth hormone or prolactin) has been common. Diagnosis requires the detection of TSH in the serum when patients are clinically and biochemically hyperthyroid. Ancillary tests supporting the diagnosis includean α-subunit to TSH molar ratio greater than 1.0, an absent TSH response to protirelin, suppression of serum TSH (but not α-subunit) by glucocorticoids, and a lack of suppression of serum TSH by dopaminergic agonists. Successful treatment of this disorder requires pituitary surgery and/or pituitary irradiation.

Original languageEnglish (US)
Pages (from-to)503-507
Number of pages5
JournalArchives of internal medicine
Issue number3
StatePublished - Mar 1983

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Hyperthyroidism due to Thyrotropin-Secreting Pituitary Tumors: Diagnostic and Therapeutic Considerations'. Together they form a unique fingerprint.

Cite this